Schedule 14A Proxy Statement - IGC Pharma, INC.

SEC

Filings

December 13, 2019

Schedule 14A Proxy Statement

Related Posts

IGC Pharma, Inc 8-K 10-10-25

October 10, 2025

IGC Pharma, Inc 8-K 10-01-25

October 1, 2025

IGC Pharma, Inc. 424B5 09-19-25

September 19, 2025

CEO Update

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025